Cramer Has a Stent Trade
On tonight’s MAD MONEY show on CNBC, Cramer reviewed what the state of the stent market will be. There is a meeting Thursday at the FDA where the FDA is going to make a…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 392Gambling Drug Fails Trials; Somaxon Shares Lower
Somaxon Pharmaceuticals (SOMX-NASDAQ) has announced essentially failed results from the company’s Phase 2/3 clinical trial evaluating 20 mg and 40 mg of oral nalmefene hydrochloride, an opiate antagonist, in patients with a diagnosis of…
Pfizer Setback Disappointing, Not Catastrophic
By Chad Brand of Peridot Capitalist I was actually planning a broader pharmaceutical post , but in light of the Pfizer (PFE) news over the weekend, I just wanted to talk about them a…
Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III
From BioHealth Investor Shares of Onyx Pharmaceuticals (ONXX) dropped more than 30% on Monday after the company announced at a teleconference that its phase III clinical trial evaluating its cancer drug Nexavar failed to…
What Elese Is Wrong With Pfizer
Pfizer (PFE) had its CEO interviwed by Mike Huckman on CNBC today. Mike Huckman even asked him how a "guy that used to sell chicken for Boston Market that is fairly new to the…
Cramer Comments on Pfizer; Also What to Expect on PFE From Here
This morning Cramer on TheStreet.com posted his comments regarding Pfizer’s (PFE) drug blow-up this weekend. You’ll need to go visit thestreet.com there about what he said exactly, but keep in mind he has been…
Pfizer Death Drug (PFE)
Those who read this column regularly know our doubts about Prizer’s new blockbuster drugs. These are the ones the are to replace all of those going off patent and into the hands of the…
Pfizer Blows It Horn To Doubting Thomases
Pfizer (PFE) met with analysts yesterday and said it was on the road to introducing some blockbuster drugs. Wall St. should hope so. With a sales force reduction of 2,000, generics snapping at its…